Nonlinearity of dose-response functions for carcinogenicity.
暂无分享,去创建一个
[1] W. Stott,et al. Genetic and nongenetic events in neoplasia. , 1981, Food and cosmetics toxicology.
[2] B. Ponder,et al. Molecular Genetics of Cancer , 1992, Nature Medicine.
[3] R. Weinberg,et al. The action of oncogenes in the cytoplasm and nucleus. , 1985, Science.
[4] S H Moolgavkar,et al. Mutation and cancer: a model for human carcinogenesis. , 1981, Journal of the National Cancer Institute.
[5] R. Albert,et al. Approach to risk assessment for genotoxic carcinogens based on data from the mouse skin initiation-promotion model. , 1983, Environmental health perspectives.
[6] A Kopp-Schneider,et al. A multistage model of carcinogenesis incorporating DNA damage and repair. , 1991, Risk analysis : an official publication of the Society for Risk Analysis.
[7] J C Bailar,et al. One-hit models of carcinogenesis: conservative or not? , 1988, Risk analysis : an official publication of the Society for Risk Analysis.
[8] W. Flamm,et al. Chemical carcinogens: a review of the science and its associated principles. U.S. Interagency Staff Group on Carcinogens. , 1986, Environmental health perspectives.
[9] C. Portier,et al. Biologically based models for risk assessment. , 1990, IARC scientific publications.
[10] F P Perera,et al. The genotoxic/epigenetic distinction: relevance to cancer policy. , 1984, Environmental research.
[11] D. Preston,et al. Dose-Response in Radiation Carcinogenesis: Animal Studies , 1985 .
[12] A J Bailer,et al. Testing for increased carcinogenicity using a survival-adjusted quantal response test. , 1989, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[13] J. Barrett,et al. Cellular and molecular mechanisms of multistep carcinogenesis: relevance to carcinogen risk assessment. , 1987, Environmental health perspectives.
[14] J. Cornfield,et al. Carcinogenic risk assessment. , 1977, Science.
[15] B. Ames,et al. Too many rodent carcinogens: mitogenesis increases mutagenesis. , 1990, Science.
[16] L. Ellwein,et al. Cell proliferation in carcinogenesis. , 1990, Science.
[17] Bailer Aj,et al. Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples. , 1988 .
[18] A J Bailer,et al. Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples. , 1988, Biometrics.
[19] M Gough,et al. Science policy choices and the estimation of cancer risk associated with exposure to TCDD. , 1988, Risk analysis : an official publication of the Society for Risk Analysis.
[20] F. A. Smith,et al. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. , 1987, Toxicology and applied pharmacology.
[21] R. Weinberg,et al. Cellular oncogenes and multistep carcinogenesis. , 1983, Science.
[22] T. Slaga,et al. Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[23] N Mantel,et al. Estimating "safe" levels, a hazardous undertaking. , 1975, Cancer research.
[24] R. Newbold,et al. Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene , 1983, Nature.
[25] S. Belinsky,et al. Cell selective alkylation of DNA in rat lung following low dose exposure to the tobacco specific carcinogen 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. , 1987, Cancer research.
[26] J H Weisburger,et al. Carcinogen testing: current problems and new approaches. , 1981, Science.
[27] D G Hoel,et al. Implication of nonlinear kinetics on risk estimation in carcinogenesis. , 1983, Science.